148 related articles for article (PubMed ID: 35367146)
1. Prognostic potential of the small GTPase Ran and its methylation in hepatocellular carcinoma.
Liu HH; Wang J; Zhang Y; Fan YC; Wang K
Hepatobiliary Pancreat Dis Int; 2022 Jun; 21(3):248-256. PubMed ID: 35367146
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of long non-coding RNA
Liao X; Chen J; Luo D; Luo B; Huang W; Xie W
Pathol Oncol Res; 2022; 28():1610808. PubMed ID: 36685103
[No Abstract] [Full Text] [Related]
3. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
4. The relationship among Girdin DNA methylation, its high expression, and immune infiltration in hepatocellular carcinoma: Clues from in silico analysis.
Zhang C; Ke Y; Lei X; Liu X; Li H; Shi R; Wang L
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33660763
[TBL] [Abstract][Full Text] [Related]
5. PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.
Yu Z; Song Y; Cai M; Jiang B; Zhang Z; Wang L; Jiang Y; Zou L; Liu X; Yu N; Mao X; Peng C; Liu S
Aging (Albany NY); 2021 Sep; 13(17):21294-21308. PubMed ID: 34470916
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.
Lu T; Li C; Xiang C; Gong Y; Peng W; Chen C
Biomed Res Int; 2022; 2022():7823191. PubMed ID: 35313629
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance.
Qiu X; Hu B; Huang Y; Deng Y; Wang X; Zheng F
Dig Dis Sci; 2016 Jan; 61(1):149-57. PubMed ID: 26386860
[TBL] [Abstract][Full Text] [Related]
9. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
Sun L; Lin Y; Wang G; Zhang L; Hu L; Lu Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439969
[TBL] [Abstract][Full Text] [Related]
10. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
[TBL] [Abstract][Full Text] [Related]
11. Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma.
Zhang T; Guan G; Chen T; Jin J; Zhang L; Yao M; Qi X; Zou J; Chen J; Lu F; Chen X
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e352-e358. PubMed ID: 29749051
[TBL] [Abstract][Full Text] [Related]
12. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
Jiang W; Wu T; Shi X; Xu J
Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
[TBL] [Abstract][Full Text] [Related]
14. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
[TBL] [Abstract][Full Text] [Related]
15. Promoter aberrant methylation status of
Chen G; Fan X; Li Y; He L; Wang S; Dai Y; Bin C; Zhou D; Lin H
Epigenetics; 2020; 15(6-7):684-701. PubMed ID: 31933413
[TBL] [Abstract][Full Text] [Related]
16. Screening and verification of microRNA promoter methylation sites in hepatocellular carcinoma.
Ni X; Lin Z; Dai S; Chen H; Chen J; Zheng C; Wu B; Ao J; Shi K; Sun H
J Cell Biochem; 2020 Jul; 121(7):3626-3641. PubMed ID: 32065423
[TBL] [Abstract][Full Text] [Related]
17. Study on the Prognostic Values of TTC36 Correlated with Immune Infiltrates and Its Methylation in Hepatocellular Carcinoma.
Jing W; Peng R; Li X; Lv S; Duan Y; Jiang S
J Immunol Res; 2022; 2022():7267131. PubMed ID: 35846428
[TBL] [Abstract][Full Text] [Related]
18. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
[TBL] [Abstract][Full Text] [Related]
19. Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma.
Shang BB; Chen J; Wang ZG; Liu H
PeerJ; 2021; 9():e12315. PubMed ID: 34754620
[TBL] [Abstract][Full Text] [Related]
20. LOXL2 serves as a prognostic biomarker for hepatocellular carcinoma by mediating immune infiltration and vasculogenic mimicry.
Zhao N; Chen C; Guo Y; Liu T; Che N; Zhang D; Liang X; Zhang Y; Zhao X
Dig Liver Dis; 2023 May; 55(5):661-672. PubMed ID: 36192339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]